One of Horizon Europe’s biggest biotechnology investments to date supports five biotechnology centres in Widening countries
Photo credits: European Union
One of Horizon Europe’s biggest investments in biotechnology so far is the €72 million awarded to five research centres in Widening countries.
We found this data by clustering together all of the Horizon Europe projects and calls relating to biotechnology. The second largest budget turns out to be part of a 2022 call in the Widening Participation and Spreading Excellence (WIDERA) programme. This funded the creation or upgrading of centres of excellence in Widening countries, states considered to have underperforming research systems.
Of the call’s €180 million total budget, €72 million went to the following five projects:
- LignoSilva, creating the Centre of Excellence of Forest-based Industry in Slovakia
- Creatic, establishing the Central European Advanced Therapy…
Discover the latest in research funding every Tuesday with Funding Newswire. Dive into detailed articles with our monthly or yearly subscriptions or start with a free trial
NOTE: if you're a part of one of our Network member organisations, you get free access by signing up with your institutional email. Verify your eligibility here.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.